← Leaderboards
Arlene O Siefker-Radtke
University Of Tx Md Anderson Can Ctr
$354,741
Attributed
$1,064,223
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $217K · FY2012–16$250K$187.5K$125K$62.5K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,064,223 · 2
By mechanism
P50$1,064,223 · 2
Top collaborators
- Colin P Dinney5 shared
- David J Mcconkey5 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- James C Yao$2,907,879
- John V. Heymach$11,138,593
- Dihua Yu$18,443,603
- Jonathan M Kurie$24,221,061
- Keith A Baggerly$843,240
Others in their field
Top investigators on “Exhibits”
- David R. Weir · University Of Michigan At Ann Arbor$259,685,758
- David W Simpson · University Of Southern California$143,628,960
- Abhik Das · Research Triangle Institute$100,700,289
- Omar N Ghattas · Carnegie Mellon University$94,000,000
- Kelly P Gaither · Purdue University$94,000,000
- Daniel Stanzione · Arizona State University$94,000,000
Research focus
ExhibitsApoptosisEpithelial To Mesenchymal TransitionEventBaseBiologicalAreaAntibodiesAngiogenesisBladderCancer CellCancer Cell LineCancer TherapyCell LineCell ProliferationCellsClinical TrialsBiological ProcessAutocrineDesignDoseEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorFgf2 Gene
Grant awards (5)
Targeting FGFR and EGFR in Bladder Cancer$215,813
P50 · FY2016 · CA
Targeting FGFR and EGFR in Bladder Cancer$217,028
P50 · FY2015 · CA
Targeting FGFR and EGFR in Bladder Cancer$214,680
P50 · FY2014 · CA
Targeting FGFR and EGFR in Bladder Cancer$213,501
P50 · FY2013 · CA
Targeting FGFR and EGFR in Bladder Cancer$203,201
P50 · FY2012 · CA